Købnhavn Ø, Denmark

Michiel Onne Elema


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michiel Onne Elema: Innovator in Pharmaceutical Composition

Introduction

Michiel Onne Elema is a notable inventor based in Købnhavn Ø, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline compositions. With a total of 2 patents to his name, Elema's work has the potential to impact the pharmaceutical industry positively.

Latest Patents

Elema's latest patents focus on crystalline compositions containing escitalopram. One of his patents discloses crystalline particles of escitalopram oxalate with a particle size of at least 40 µm. The patent also includes methods for the manufacture of these crystalline particles and pharmaceutical compositions that comprise them. This innovation could enhance the efficacy and delivery of escitalopram in medical applications.

Career Highlights

Elema is currently associated with H. Lundbeck A/S, a prominent company in the pharmaceutical sector. His work at Lundbeck has allowed him to explore and develop innovative solutions in drug formulation and delivery. His expertise in crystalline compositions is a testament to his commitment to advancing pharmaceutical science.

Collaborations

Throughout his career, Elema has collaborated with talented professionals in the field. Notable coworkers include Troels Volsgaard Christensen and Ken Liljegren, who have contributed to various projects alongside him. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Michiel Onne Elema is a distinguished inventor whose work in pharmaceutical compositions is paving the way for advancements in drug delivery systems. His contributions, particularly in the area of escitalopram formulations, highlight his dedication to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…